Question

Difficulty: Very hardNeurocognitive Disorders

An internal medicine physician is evaluating a 76-year-old male patient who presents with his daughter due to concerns about his worsening memory and unusual behavior over the past 14 months. The daughter reports that his cognitive abilities fluctuate drastically; on some days he is highly conversational and independent, while on other days he stares blankly for hours and requires help with dressing. He frequently reports seeing "small animals" hiding in the corners of his room. His medical history includes hypertension, benign prostatic hyperplasia, and Bipolar I disorder. He discontinued his mood stabilizer 5 years ago against medical advice but has remained euthymic since. Current medications include amlodipine, tamsulosin, and carbidopa-levodopa, which was initiated two months ago by a neurologist for a newly developed resting tremor and bradykinesia.

The patient's daughter is his legally appointed healthcare proxy via a verified advance directive. However, his estranged son is also present at the visit and demands that the physician immediately prescribe a strong medication to "stop the crazy visions," explicitly overriding his sister's request for a cautious approach.

On mental status examination, the patient is alert but oriented only to person. He scores 19/3019/30 on the Montreal Cognitive Assessment, with pronounced deficits in visuospatial function and executive tasks. Physical examination reveals bilateral cogwheel rigidity in the upper extremities.

Which of the following is the most appropriate next step in the management of this patient?

  1. Initiate a cholinesterase inhibitor and discuss the disease trajectory with the daughterAnswer
  2. B
    Obtain informed consent from the son to initiate a second-generation antipsychotic
  3. C
    Initiate haloperidol to rapidly control the visual hallucinations
  4. D
    Diagnose late-onset schizophrenia and initiate long-acting risperidone
  5. E
    Initiate fluoxetine monotherapy to target a suspected depressive episode

Answer

Initiate a cholinesterase inhibitor and discuss the disease trajectory with the daughter
The correct answer synthesizes three critical elements of this case. First, the clinical triad of fluctuating cognition, well-formed visual hallucinations, and spontaneous parkinsonism establishes the diagnosis of Major Neurocognitive Disorder with Lewy Bodies (DLB). Second, the standard of care for initial pharmacologic management of both cognitive and neuropsychiatric symptoms in DLB is a cholinesterase inhibitor (e.g., rivastigmine or donepezil). Third, from an ethical standpoint, the physician must legally defer to the patient's daughter, as she is the designated healthcare proxy, and disregard the conflicting demands of the estranged son.

Step-by-Step Solution

1
Analyze the patient's clinical signs and timeline.
Identified a 14-month history of fluctuating cognition, complex visual hallucinations, and spontaneous parkinsonism (rigidity, tremor).
These three core features definitively meet the diagnostic criteria for Major Neurocognitive Disorder with Lewy Bodies (DLB).
2
Evaluate the ethical dilemma regarding surrogate decision-making.
Identified that the daughter is the legally appointed healthcare proxy via an advance directive.
Legally designated proxies have priority over all other next-of-kin, meaning the son's demands must be ethically overridden.
3
Determine the optimal pharmacologic management for DLB while avoiding contraindicated therapies.
Selected a cholinesterase inhibitor while avoiding typical antipsychotics and inappropriate SSRI monotherapy.
Cholinesterase inhibitors treat both the cognitive and behavioral symptoms in DLB safely, whereas neuroleptics trigger severe sensitivity reactions and SSRI monotherapy risks manic switch in bipolar history.

Key Concept

Diagnosis and management of Major Neurocognitive Disorder with Lewy Bodies (DLB), including surrogate decision-making ethics.
Estimated Time:2m 0s
Rate this question